Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Delirium × Lorazepam × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vomiting 2 Nausea 2 Sarcoma, Alveolar Soft Part 1 Pain 1 Neurotoxicity Syndromes 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Delirium 1 Breast Neoplasms 1

Interventions

haloperidol decanoate 1 Surveys and Questionnaires 1 Lorazepam 1 Haloperidol 1 Chlorpromazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡